| Financial Year |
March 31 2023 |
| Monetary Funds |
700,865,930.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
42,405,154.48 |
| Advances to Suppliers |
19,741,013.54 |
| Other Receivables |
19,809,855.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
507,263,234.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,662,859.25 |
| Other Current Assets |
6,502,866.70 |
| Total Current Assets |
1,300,250,914.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,742,158.86 |
| Long-term Equity Investment |
1,406,048.06 |
| Investment Properties |
-- |
| Fixed Assetes |
2,483,033,440.91 |
| Under-construction Projects |
134,452,914.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
221,120,174.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,727,331.78 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
33,092,476.36 |
| Sub-Total of Non-Current Assets |
2,950,103,338.71 |
| Total Assets |
4,250,354,252.97 |
| Short-Term Loans |
510,167,156.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,039,222.59 |
| Accounts Payable |
219,022,473.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,975,620.63 |
| Taxes Payable |
4,931,036.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
266,150,515.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
174,327,793.18 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,239,845,044.98 |
| Long-term Loans |
403,811,331.08 |
| Bonds Payable |
583,918,475.08 |
| Long-Term Accounts Payable |
83,570,492.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,140,897,385.92 |
| Total Liabilities |
2,380,742,430.90 |
| Paid-In Capital(Or Share Stock) |
503,044,448.00 |
| Capital Surplus |
764,390,912.48 |
| Surplus Reserve |
94,760,263.95 |
| LESS:Treasury Stock |
16,431,894.03 |
| Undistributed Profits |
565,106,189.70 |
| Minority Stockholder's Interest |
-106,777,435.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,976,389,257.43 |
| Owner's Equity（Stockholder's Equity） |
1,869,611,822.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,250,354,252.97 |
